Intravenous lidocaine for inducing remission of cluster period

Cluster headache is a rare clinical condition, classified by the IHS as a trigeminal autonomic cephalalgia. Some known abortive treatments are inhaled oxygen, subcutaneous sumatriptan, intravenous dihydroergotamine and intranasal lidocaine. However, previous case reports suggest that intravenous lid...

Full description

Saved in:
Bibliographic Details
Published inRevista Headache Medicine (Online) pp. 41 - 43
Main Authors Santos, Paulo Sérgio Faro, Iachinski, Renato Endler, Sato, Henry Koiti, Nascimento, Maria Tereza Moraes Souza, Souza, Ricardo Krause Martinez de, Rizelio, Vanessa, Kowacs, Pedro André
Format Journal Article
LanguageEnglish
Published 31.03.2012
Online AccessGet full text

Cover

More Information
Summary:Cluster headache is a rare clinical condition, classified by the IHS as a trigeminal autonomic cephalalgia. Some known abortive treatments are inhaled oxygen, subcutaneous sumatriptan, intravenous dihydroergotamine and intranasal lidocaine. However, previous case reports suggest that intravenous lidocaine may play a role in the treatment of cluster headache attacks. We describe a patient with refractory cluster headache, whose condition remitted after the use of intravenous lidocaine. Therapy with lidocaine was conducted without harm, and the remission after a "single shot" suggested this approach to be safe and desirable to be tried in patients with cluster headache..
ISSN:2763-6178
2763-6178
DOI:10.48208/HeadacheMed.2012.7